chronic treatment of rats with the antipsychotic drug molindone ( 2.5 mg/kg ) did not elicit behavioral supersensitivity to apomorphine ( ap ) ( 0.25 mg/kg ) or increased striatal 3h-spiroperidol binding , whereas treatment with haloperidol ( 0.5-1.0 mg/kg ) produced manifestations of dopaminergic supersensitivity in both paradigms .
C0040615
antipsychotic drug
C0026388
molindone